Aamir Shahzad, Randall J Cohrs, Adong Shen and Cornelia Lass-Fl
Human Fungal Infections: Need to Improve Diagnosis with New Biomarkers Developed by Translational Research
The burden of invasive fungal disease (IFD) continues to increase as a result of improved medical intervention and supportive care. The growing number of patients with a variety of risk factors (e.g. transplantation, chemotherapy, HIV infection, use of corticosteroids or new immunosuppressive agents) have caused an increase in incidence of invasive infections in recent years. Millions of individuals worldwide are affected or at risk and mortality is high.